クリス・ハードウィックのインスタグラム(nerdist) - 7月16日 06時01分

The results, published in The New England Journal of Medicine, showed an appropriate immune response from all participants, as well as no “trial-limiting safety concerns.” These positive results pave the way for a new trial that’s set to begin on July 27 and include 30,000 participants.⁠
link in bio

[BIHAKUEN]UVシールド(UVShield)

>> 飲む日焼け止め！「UVシールド」を購入する